课题基金 / 基金详情

项目摘要

项目成果

David Eschenbach的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There is evidence that afebrile women in premature labor can be infected. Organisms are present in the amniotic fluid of 10% of the women in premature labor. Organisms can be isolated from between the chorion and amnion of 60% of the women who deliver prematurely, in contrast to only 20% of women who deliver at term. The major objective of this study is to define the microbiology and histopathology of women in premature labor and to treat the women in premature labor with antibiotics. The specific aims are: 1) define the vaginal/cervical, amniotic fluid and placental microbiology of women in premature labor, 2) study selected microbiologic factors associated with infection, 3) demonstrate that antibiotics given to women in premature labor will reduce premature deliveries compared to placebo treated women, 4) demonstrate that placental and decidual inflammation is highly correlated with both infection and preterm delivery, and 5) evaluate defense mechanisms which may protect against infection. We plan to conduct a case-control study in which cases consisting of afebrile women in premature labor with intact membranes will undergo vaginal/cervical and trans-abdominal amniotic fluid cultures. These women will be placed in a randomized double- blinded trial of intravenous mezlocillin and oral erythromycin or saline placebo. The control group will be stratified into women who deliver at 34-37 and greater than 37 weeks of pregnancy. After delivery, cultures of the chorion-amnion and histology of the placental and endometrium will be performed. To evaluate the effect of infection on pregnancy the presence of vaginal/cervical, endometrial, placental membrane and amniotic organisms and/or inflammation will be compared among 450 causes and 450 control women. We will evaluate whether high organism concentration or organism virulence will positively correlate with infection and whether selected organisms, amniotic fluid bacterial inhibitory factors and serum antibody will negatively correlate with infection. It is hoped that the result of these studies will demonstrate the microbiology and pathophysiology of infection among women in premature labor and that antibiotic therapy will reduce the rate of premature births.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Women's Reproductive Health Research at the Univ of WA
  • 批准号:
    8321592
  • 项目类别:
  • 资助金额:
    $47.34万
  • 财政年份:
    1998
  • 负责人:
    David Eschenbach
  • 依托单位:
Women's Reproductive Health Research at the Univ of WA
  • 批准号:
    6892116
  • 项目类别:
  • 资助金额:
    $24.99万
  • 财政年份:
    1998
  • 负责人:
    David Eschenbach
  • 依托单位:
Women's Reproductive Health Research at the Univ of WA
  • 批准号:
    8135531
  • 项目类别:
  • 资助金额:
    $4.0万
  • 财政年份:
    1998
  • 负责人:
    David Eschenbach
  • 依托单位:
Women's Reproductive Health Research at the Univ of WA
  • 批准号:
    7797147
  • 项目类别:
  • 资助金额:
    $47.34万
  • 财政年份:
    1998
  • 负责人:
    David Eschenbach
  • 依托单位:
国内基金
海外基金
瘤内细菌 Lactobacillus iners 通过 eIF4A2 乳酸化介导肿瘤相关巨噬细胞极 化诱导膀胱癌免疫化疗抵抗的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    吴志明
  • 依托单位:
肠道菌群Lactobacillus来源的吲哚-3- 甲醛对绝经后骨量丢失的保护机制研究
Lactobacillus reuteri调控FTO/CMPK2/NLRP3信号轴介导炎症反应治疗5-FU诱导的口腔粘膜炎的作用研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    邱敬诚
  • 依托单位:
葛根交泰丸调控Lactobacillus介导胆汁酸“肠-肝轴”途径治疗2型糖尿病的机制研究
  • 批准号:
    82305009
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    王文波
  • 依托单位: